FEMY: Femasys Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 28.29
Enterprise Value ($M) 14.92
Book Value ($M) 15.61
Book Value / Share 0.71
Price / Book 1.81
NCAV ($M) 11.12
NCAV / Share 0.50
Price / NCAV 2.54

Profitability (mra)
Return on Invested Capital (ROIC) -0.66
Return on Assets (ROA) -1.07
Return on Equity (ROE) -1.21

Liquidity (mrq)
Quick Ratio 8.02
Current Ratio 8.43

Balance Sheet (mrq) ($M)
Current Assets 19.88
Assets 24.37
Liabilities 8.76
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.07
Operating Income -14.51
Net Income -14.25

Cash Flow Statement (mra) ($M)
Cash From Operations -11.28
Cash from Investing -0.14
Cash from Financing 20.18

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-22 13D PharmaCyte Biotech, Inc. 37.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-07-24 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 2)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 50,403 241,999 20.83
2024-05-16 27,845 133,928 20.79
2024-05-15 21,147 158,543 13.34
2024-05-14 46,325 183,989 25.18
2024-05-13 77,190 182,457 42.31

(click for more detail)

Similar Companies
DYNT – Dynatronics Corporation ECOR – electroCore, Inc.
ESTA – Establishment Labs Holdings Inc. FONR – FONAR Corporation
GCTK – GlucoTrack, Inc.


Financial data and stock pages provided by
Fintel.io